Nanosonics share price on watch after tripling its operating profit in FY 2019

The Nanosonics Ltd (ASX:NAN) share price could be on the move today after tripling its operating profit in FY 2019…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price will be one to watch this morning following the announcement of a strong profit result in FY 2019.

What did Nanosonics announce?

For the 12 months to June 30, Nanosonics reported record full year sales of $84.3 million, which was a 39% increase on the prior corresponding period.

This top line result was driven by strong growth in both Capital revenue and Consumable and Service revenue. Capital revenue increased 28% to $32.8 million and Consumables and Service revenue jumped 47% to $51.5 million. The latter reflected the annuity revenue associated with continuing strong growth in the company's installed base.

That installed base continued its solid growth in FY 2019. Management advised that its global installed base reached 20,930 units at the end of the period, which was an 18% increase year on year.

Operating expenses for the year were $49.2 million, including $11.4 million in Research and Development, which was up 16% on prior corresponding period.

This ultimately led to Nanosonics posting operating profit before tax of $16.8 million, which was up a massive 201% on the prior corresponding period.

Nanosonics' Chief Executive Officer and President, Michael Kavanagh, was very pleased with the company's performance in FY 2019.

He said: "The organisation has continued to go from strength to strength delivering excellent growth in our core trophon business while making significant investments in our long term strategy of establishing Nanosonics as a globally recognised leader in infection prevention."

"During the year the 2nd generation trophon, trophon2, was successfully launched receiving very positive customer feedback. Importantly, large investments in our product expansion strategy were made with significant development milestones achieved towards meeting the goal of introducing the first major new product by end of FY20, subject to regulatory approval," added Mr Kavanagh.

Outlook.

In FY 2020 the company expects continued growth in the installed base in North America with an adoption rate similar to FY 2019. It also expects adoption in Europe to grow thanks to its expanded geographical reach and growing awareness.

In addition to this, it advised that its renegotiated distribution agreement with GE Healthcare in the USA has now come into effect. This new agreement expands distribution opportunities globally and also results in a material increase in both sales and margin from consumables in the region. The full impact of which will be realised from the second half of FY 2020.

Operating costs are expected to increase by a sizeable 36% to $67 million this year due to its accelerated investment in growth. This includes $15 million in R&D spending.

Overall, "FY20 profit will be heavily weighted to H2 FY20, taking into consideration: the planned increased investment in new products and geographical expansion of the base trophon business; phasing of trophon sales; and the realisation of consumables margin benefit associated with the new GE Healthcare distribution agreement, the full benefit of which comes into effect in H2 FY20."

Should you invest $1,000 in Dicker Data right now?

Before you buy Dicker Data shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Dicker Data wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Hub24 Ltd and Nanosonics Limited. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool Australia has recommended Hub24 Ltd and Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Opinions

Where I'd invest in ASX shares after the RBA interest rate cut

These stocks look really attractive to me. Here’s why…

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Share Market News

5 things to watch on the ASX 200 on Wednesday

A good session is expected for Aussie investors on hump day.

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares returned to positive territory this Tuesday.

Read more »

Multiple percentage signs in the palm of a man's hand.
Share Market News

ASX 200 lifts on the RBA's latest interest rate call

The ASX 200 is up 0.5% on the heels of the RBA’s interest rate announcement.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Macquarie tips 40% upside for this ASX 200 real estate stock

Let's see what the broker is saying about this stock.

Read more »

Woman sits at her desk working at night, while traffic flows on a busy freeway out the window behind her.
Broker Notes

Transurban shares: Buy, hold, sell? Here's Macquarie's recommendation

Macquarie’s analysts just ran their slide rules over Transurban shares. Here’s what they found.

Read more »

A woman sits at her home computer with baby on her lap, and the winning ticket in her hand.
Consumer Staples & Discretionary Shares

Which 'enduring high-quality business' has become a forgotten ASX 200 stock?

Fundie says this ASX 200 consumer discretionary stock has been flying under investors' radar.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Financial Shares

Want a financial stock outside the big 4 banks? Macquarie tips 15% upside for this small cap financial

For those searching on the edges, this name could be worth a second look according to Macquarie.

Read more »